Participants

AbbVie Ventures
Acorda Therapeutics
Advanced Regenerative Manufacturing Institute
Agios Pharmaceuticals
Alexandria Real Estate Equities
Aquilo Partners
Arrakis Therapeutics
Axcella Health, Inc.
Back Bay Life Science Advisors
Baillie Gifford
Biogen
BioInnovation Capital
BioVentures Investors
Boston Pharmaceuticals
Broad Institute
Canaan Partners
CBT Advisors
Cerevance, Inc.
Churchill Pharma LLC
CRISPR Therapeutics
DalCor Pharmaceuticals
Decibel Therapeutics
DeuteRx
EMD Serono

Eleven Biotherapeutics Inc.
Emerging BioCommunications
Empiriko
Evotec AG
Flagship Pioneering
Foley & Lardner
F-Prime Capital Partners
Frazier Healthcare Partners
Frequency Therapeutics
GNS Healthcare
GrayBella Capital
Halloran Consulting Group
Harvard Medical School
Ipsen
IRX Therapeutics
Johnson & Johnson
Kaleido Biosciences
Koch Institute at MIT
Longitude Capital
Lysosomal Therapeutics
MacDougall Biomedical Communications
Marine Biological Laboratory
Merck
Merieux Developpement
Mersana Therapeutics

Mirata Pharmaceuticals
Moderna Therapeutics
Momenta Pharmaceuticals
MRL Ventures Fund
Myovant
Navitor Pharmaceuticals
NGM Biopharmaceuticals
Nitto Avecia Inc.
Northeastern University
Obsidian Therapeutic
Omega Funds
Oncorus
Ovid Therapeutics Inc.
Oxford Finance LLC
Park Square Executive Search
Partners HealthCare Innovation
PBL Assay Science
Potenza Therapuetics
Prognos
RA Capital Management
Realm Therapeutics, Inc.

RMG Associates, LLC
Sanofi
Sensei Bio
Stat
Stromasys
Sucampo Pharmaceuticals
Sunovion Pharmaceuticals Inc.
SV Health Investors
Synlogic Therapeutics
Takeda Pharmaceuticals International
Tarveda Therapeutics
Teva Pharmaceuticals
Third Rock Ventures
Tilos Therapeutics
TriNetX
USB
Vertex Pharmaceuticals Inc.
Wolfe Laboratories
Xontogeny
XTuit Pharmaceuticals, Inc.
Zafgen